157 related articles for article (PubMed ID: 34635434)
1. Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis.
Chen ZH; Feng JK; Sun JX; Wu JY; Guo WX; Shi J; Wei YG; Zhou JY; Zhang ZB; Yan ML; Cheng SQ
HPB (Oxford); 2022 Apr; 24(4):547-557. PubMed ID: 34635434
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
Zhang XP; Liu YC; Chen ZH; Sun JX; Wang K; Chai ZT; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2019 May; 26(5):1465-1473. PubMed ID: 30767178
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.
Huang Q; Lin K; Wang L; Zeng J; Liu H; Ding Z; Zeng Y; Liu J
Cancer Manag Res; 2020; 12():9183-9195. PubMed ID: 33061610
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis.
Liu ZH; Sun JX; Feng JK; Yang SY; Chen ZH; Liu C; Chai ZT; Mao FF; Guo WX; Shi J; Cheng SQ
Front Oncol; 2022; 12():835559. PubMed ID: 35372001
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
6. Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis.
Wu JY; Sun JX; Wu JY; Huang XX; Bai YN; Wei YG; Zhang ZB; Zhou JY; Cheng SQ; Yan ML
Ann Surg Oncol; 2022 Feb; 29(2):949-958. PubMed ID: 34591226
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort.
Luo L; Shan R; Cui L; Wu Z; Qian J; Tu S; Zhang W; Xiong Y; Lin W; Tang H; Zhang Y; Zhu J; Huang Z; Li Z; Mao S; Li H; Hu Z; Peng P; He K; Li Y; Liu L; Shen W; He Y
United European Gastroenterol J; 2023 Mar; 11(2):228-241. PubMed ID: 36905230
[TBL] [Abstract][Full Text] [Related]
8. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
Ke Q; Xiang F; Xiao C; Huang Q; Liu X; Zeng Y; Wang L; Liu J
BMC Cancer; 2021 Oct; 21(1):1117. PubMed ID: 34663242
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China.
Wu Z; Cui L; Qian J; Luo L; Tu S; Cheng F; Yuan L; Zhang W; Lin W; Tang H; Li X; Li H; Zhang Y; Zhu J; Li Y; Xiong Y; Hu Z; Peng P; He Y; Liu L; He K; Shen W
BMC Cancer; 2023 Apr; 23(1):325. PubMed ID: 37029339
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.
Xu JX; Qin SL; Wei HW; Chen YY; Peng YC; Qi LN
Ann Med; 2023 Dec; 55(1):2199219. PubMed ID: 37070467
[TBL] [Abstract][Full Text] [Related]
11. Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study.
Xiang YJ; Sun JX; Wu JY; Wang K; Feng JK; Wei YG; Zhou JY; Zhang ZB; Zhang YQ; Qin YY; Yan ML; Cheng SQ
HPB (Oxford); 2022 Oct; 24(10):1703-1710. PubMed ID: 35523655
[TBL] [Abstract][Full Text] [Related]
12. Concurrent bile duct resection versus concomitant thrombectomy for hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis.
Feng JK; Chen ZH; Sun JX; Wu JY; Guo WX; Shi J; Wei YG; Zhou JY; Zhang ZB; Yan ML; Cheng SQ
Ann Transl Med; 2021 Mar; 9(6):457. PubMed ID: 33850854
[TBL] [Abstract][Full Text] [Related]
13. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma.
Wang H; Yu H; Qian YW; Cao ZY; Wu MC; Cong WM
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):232-239. PubMed ID: 33455865
[TBL] [Abstract][Full Text] [Related]
15. Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study.
Wang Y; Ge H; Hu M; Pan C; Ye M; Yadav DK; Zheng R; Wu J; Sun K; Wang M; Tian Y; Huang J; Yao W; Li J; Zhang Q; Liang T
Int J Surg; 2022 Sep; 105():106852. PubMed ID: 36030036
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study.
Wang L; Lin N; Lin K; Xiao C; Wang R; Chen J; Zhou W; Liu J
J Gastrointest Surg; 2021 May; 25(5):1172-1183. PubMed ID: 32440804
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis.
Wu JY; Sun JX; Bai YN; Huang XX; Wu JY; Wei YG; Zhang ZB; Zhou JY; Wang YD; Cheng SQ; Yan ML
Ann Surg Oncol; 2021 Nov; 28(12):7686-7695. PubMed ID: 33929619
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis.
Shen L; Chen S; Qiu Z; Qi H; Yuan H; Cao F; Xie L; Chen Q; Li W; Fan W
J Cancer Res Ther; 2020 Sep; 16(5):1063-1068. PubMed ID: 33004748
[TBL] [Abstract][Full Text] [Related]
19. Preoperative transarterial chemoembolization for barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the milan criteria: a propensity score matching analysis.
Guo C; Zou X; Hong Z; Sun J; Xiao W; Sun K; Li X; Shen Y; Liang T; Bai X
HPB (Oxford); 2021 Sep; 23(9):1427-1438. PubMed ID: 33715958
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation.
Zhou Q; An Y; Liu T; Liu Z; Li R; Wang C; Zhou F; Liu C; Zhu K
Int J Hyperthermia; 2022; 39(1):97-107. PubMed ID: 34979845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
